Literature DB >> 4999282

Some observations on the genetics of isoniazid resistance in the tubercle bacilli.

H L David, C M Newman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4999282     DOI： 10.1164/arrd.1971.104.4.508

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  12 in total

1.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; N D Connell; B N Kreiswirth; T S Whittam; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

3.  Genetic antagonism and hypermutability in Mycobacterium smegmatis.

Authors:  P Karunakaran; J Davies
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

Review 4.  Molecular epidemiology of tuberculosis: current insights.

Authors:  Barun Mathema; Natalia E Kurepina; Pablo J Bifani; Barry N Kreiswirth
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 5.  Evolution of drug-resistant tuberculosis: a tale of two species.

Authors:  M D Iseman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase.

Authors:  A'Lissa B Gerum; Jonathan E Ulmer; David P Jacobus; Norman P Jensen; David R Sherman; Carol Hopkins Sibley
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure.

Authors:  J M Musser; A Amin; S Ramaswamy
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

8.  Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis.

Authors:  I J Eltringham; F A Drobniewski; J A Mangan; P D Butcher; S M Wilson
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Susceptibility of mycobacteria to rifampin.

Authors:  C L Woodley; J O Kilburn; H L David; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

10.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.